Displaying 1 - 20 of 45
Active Ingredient AUTONOMIC DRUGS
Therapeutic Class AUTONOMIC DRUGS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient CYCLOBENZAPRINE
Therapeutic Class CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
Indications Acute muscle spasm of local origin.
Caution Drowsiness, dizziness, insomnia, anxiety , restlessness, confusion, extrapyramidal symptoms, anticholinergic effects, allergic skin reactions.
Dose Range 10mg three times daily . Maximum dose is 60mg daily . See BDS supply protocols pg. 11.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient BLOOD FORMATION AND COAGULATION
Therapeutic Class BLOOD FORMATION, COAGULATION AND THROMBOSIS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient ANTIANAEMIA DRUGS
Therapeutic Class ANTIANEMIA DRUGS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient FERROUS FUMARATE
Therapeutic Class IRON PREPARATIONS
Indications Iron deficiency, anaemia.
Caution Black stools, constipation. As for ferrous sulphate/folic acid.Liquid may be taken in water or juice to prevent staining of teeth. Antacids decrease absorption.
Dose Range Adult: One tablet 3 times daily. Take with food.Pediatric: 3-
6mg/kg daily (maximum 200mg) in 2-3 divided doses.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient FERROUS FUMARATE | FOLIC ACID
Therapeutic Class IRON PREPARATIONS
Indications Prophylaxis of iron and folic acid
Caution Do not take within 2 hours of oral tetracy clines. G.I symptoms.Black stools, constipation. As for ferrous sulphate/folic acid.Liquid
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient FERROUS SULPHATE
Therapeutic Class IRON PREPARATIONS
Indications Iron deficiency, anaemia.
Caution Do not take within 2 hours of oral tetracy clines. G.I symptoms.Black stools, constipation. As for ferrous sulphate/folic acid.Liquid
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient FERROUS SULPHATE | FOLIC ACID
Therapeutic Class IRON PREPARATIONS
Indications Prophylaxis of iron and folic acid deficiencies in pregnancy.
Caution Do not take within 2 hours of oral tetracyclines. G.I. symptoms.
Dose Range Adult: 1-3 tabs daily. Paediatic 6: 12 yrs: 5 mls daily. 2-5 years: 2.5ml daily. Under 2 years:1.25 ml daily.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient FOLIC ACID IRON 3 HYDROXY POLYMALTOSE
Therapeutic Class IRON PREPARATIONS
Indications Prophylaxis of iron and folic acid deficiencies.
Caution Occasional G.I. upset.
Dose Range One tablet daily .
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient FOLIC ACID | IRON 3 HYDROXY POLYMALTOSE
Therapeutic Class IRON PREPARATIONS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient IRON 3 HYDROXY POLYMALTOSE
Therapeutic Class IRON PREPARATIONS
Indications Iron deficiency anemia.
Caution Occasional G.I. upset.
Dose Range One tablet, 10ml syrup or 2ml drops contains 100mg elemental iron. Syrup: Infants: 2.5ml-5ml daily . Pediatric: 5ml 1-2 times daily . Adult: 5ml 2-3 times daily . Tablet: One tablet 1-3 times daily . Drops: Infants: As a supplement 2mg/kg/day ; as
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient EYE, EAR, NOSE AND THROAT PREPARATIONS
Therapeutic Class EYE, EAR, NOSE AND THROAT PREPARATIONS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient ACARBOSE
Therapeutic Class ALPHA GLUCOSIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient METFORMIN
Therapeutic Class BIGUANIDES
Indications Diabetes mellitus in obese, mature onset, diabetes without ketosis,
when diet and attempts at weight loss fail.
Caution Anorexia or dyspep sia occurs in 15% of cases. Lactic acidosis is an
infrequent side effect. Nausea, vomiting, diarrhoea, flatulence. C.f.
Prescribing in liver and renal disease p. 15; 32. Not recom More ...
Dose Range 500mg 2-3 times daily or 850mg once or twice daily with or after
meals. Gradually increase at intervals of at least 1 week, to 2- 3 g
daily . Doses greater than 2g, give in 3 divided doses. Extended Release: Initial dose of 500 mg once daily in
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient METFORMIN XR
Therapeutic Class BIGUANIDES
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient LINAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient METFORMIN XR | SITAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient METFORMIN | SAXAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient METFORMIN | SITAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient METFORMIN | VILDAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding